Volume | 1,289,138 |
|
|||||
News | - | ||||||
Day High | 47.16 | Low High |
|||||
Day Low | 44.0101 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Crinetics Pharmaceuticals Inc | CRNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
44.52 | 44.0101 | 47.16 | 46.81 | 44.43 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,538 | 1,289,138 | $ 45.54 | $ 58,706,532 | - | 15.23 - 47.58 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:30:03 | 10 | $ 46.81 | USD |
Crinetics Pharmaceuticals (CRNX) Options Flow Summary
Crinetics Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.26B | 69.60M | - | 4.01M | -214.53M | -3.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Crinetics Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRNX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 45.86 | 47.16 | 42.33 | 44.11 | 713,563 | 0.95 | 2.07% |
1 Month | 45.09 | 47.58 | 37.44 | 42.85 | 922,780 | 1.72 | 3.81% |
3 Months | 35.22 | 47.58 | 33.67 | 39.84 | 756,847 | 11.59 | 32.91% |
6 Months | 28.20 | 47.58 | 25.35 | 34.76 | 837,778 | 18.61 | 65.99% |
1 Year | 15.76 | 47.58 | 15.23 | 29.02 | 869,972 | 31.05 | 197.02% |
3 Years | 15.70 | 47.58 | 14.84 | 25.54 | 477,382 | 31.11 | 198.15% |
5 Years | 22.50 | 47.58 | 10.63 | 24.40 | 329,558 | 24.31 | 108.04% |
Crinetics Pharmaceuticals Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. |